Literature DB >> 3687591

Roles of kallikrein-kinin system in acute inflammation: studies on high- and low-molecular weight kininogens-deficient rats (B/N-Katholiek strain).

S Oh-ishi1, I Hayashi, I Utsunomiya, M Hayashi, K Yamaki, A Yamasu, T Nakano.   

Abstract

Carrageenin-induced paw edema in HMW- and LMW-kininogens-deficient rats was significantly less than that in normal rats. There are three kininogens, HMW-, LMW- and T-kininogens, in normal rat plasma, but B/N-Katholiek rat plasma contains only T-kininogen. The pretreatment with captopril, a kiniase II inhibitor, enhanced paw swelling of normal rats, but not that of the deficient rats, indicating that bradykinin released from HMW-kininogen may have a role for the swelling but T-kinin may not be released in this inflammation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3687591     DOI: 10.1007/bf01966523

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  Primary structures of the mRNAs encoding the rat precursors for bradykinin and T-kinin. Structural relationship of kininogens with major acute phase protein and alpha 1-cysteine proteinase inhibitor.

Authors:  S Furuto-Kato; A Matsumoto; N Kitamura; S Nakanishi
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

2.  A radioimmunoassay for rat T-kininogen as an acute phase reactant.

Authors:  I Hayashi; S Oh-ishi; K Enjyoji; H Kato; S Iwanaga
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-08       Impact factor: 1.645

3.  Isolation and structure of T-kinin.

Authors:  H Okamoto; L M Greenbaum
Journal:  Biochem Biophys Res Commun       Date:  1983-04-29       Impact factor: 3.575

4.  Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat.

Authors:  J Damas; A Adam
Journal:  Experientia       Date:  1980-05-15

5.  Prolonged activated partial thromboplastin time and deficiency of high molecular weight kininogen in brown Norway rat mutant (Katholiek strain).

Authors:  S Oh-ishi; I Hayashi; K Satoh; T Nakano
Journal:  Thromb Res       Date:  1984-02-15       Impact factor: 3.944

6.  Evidence for a role of the plasma kallikrein-kinin system in acute inflammation: reduced exudation during carrageenin- and kaolin-pleurisies in kininogen-deficient rats.

Authors:  S Oh-Ishi; I Hayashi; M Hayashi; K Yamaki; A Yamasu; T Nakano; I Utsunomiya; Y Nagashima
Journal:  Agents Actions       Date:  1986-06

7.  Identification of T-kininogen in high and low molecular weight kininogens deficient rat (brown Norway Katholiek strain).

Authors:  I Hayashi; S Oh-ishi; H Kato; K Enjyoji; S Iwanaga; T Nakano
Journal:  Thromb Res       Date:  1985-08-01       Impact factor: 3.944

8.  The role of the kinin system in various inflammatory models in the rat.

Authors:  J Damas; G Remacle-Volon; A Adam
Journal:  Int J Tissue React       Date:  1984
  8 in total
  6 in total

1.  Reduction of sodium deoxycholic acid-induced scratching behaviour by bradykinin B2 receptor antagonists.

Authors:  I Hayashi; M Majima
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Pro-inflammatory properties of the kallikrein-kinin system: potential for new drug therapy.

Authors:  J N Sharma; A P Yusof
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

3.  Kinins and peritoneal exudates induced by carrageenin and zymosan in rats.

Authors:  J Damas; V Bourdon; G Remacle-Volon; A Adam
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Comparative study of endotoxin-induced hypotension in kininogen-deficient rats with that in normal rats.

Authors:  A Ueno; H Ishida; S Oh-ishi
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

5.  Presence of T-kininogen and kinins in sponge-induced exudates in rats.

Authors:  J Damas; A Adam; V Bourdon; G Remacle-Volon
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

Review 6.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.